OSE Immunotherapeutics SA
PAR:OSE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
OSE Immunotherapeutics SA
PAR:OSE
|
FR |
|
C
|
China Merchants Bank Co Ltd
XMUN:M4B
|
CN |
|
R
|
Rush Enterprises Inc
NASDAQ:RUSHB
|
US |
|
Servizi Italia SpA
MIL:SRI
|
IT |
|
Centaurus Metals Ltd
ASX:CTM
|
AU |
|
Metrovacesa SA
MAD:MVC
|
ES |
|
B
|
Bridgestone Corp
DUS:BGT
|
JP |
|
B
|
BioNxt Solutions Inc
CNSX:BNXT
|
CA |
|
Critical Elements Lithium Corp
F:F12
|
CA |
|
F
|
Fluor Corp
DUS:FLU
|
US |
|
P
|
Pultegroup Inc
BMV:PHM
|
US |
|
Orkla ASA
OTC:ORKLY
|
NO |
|
Cytokinetics Inc
NASDAQ:CYTK
|
US |
|
Atomic Eagle Ltd
ASX:AEU
|
AU |
|
Lifestyle Communities Ltd
ASX:LIC
|
AU |
|
U
|
United Therapeutics Corp
F:UTH
|
US |
|
H
|
Hantop Inc
KOSDAQ:002680
|
KR |
|
Komatsu Ltd
F:KOMA
|
JP |
|
I
|
Industrial and Commercial Bank of China Ltd
DUS:ICK
|
CN |
|
S
|
Societe Anonyme des Bains de Mer et du Cercle des Etrangers a Monaco SA
XMUN:RJ8
|
MC |
|
G
|
Grand Canal Land PCL
SET:GLAND
|
TH |
|
C
|
China Rare Earth Holdings Ltd
XMUN:RAE
|
CN |
|
China Pacific Insurance Group Co Ltd
SSE:601601
|
CN |
|
XBiotech Inc
NASDAQ:XBIT
|
US |
Bankruptcy Probability
OSE Immunotherapeutics SA's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
OSE Immunotherapeutics SA Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| FR |
|
OSE Immunotherapeutics SA
PAR:OSE
|
43.8m EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
513.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
249.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
205.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
136.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
88.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
84.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
62.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
88.4B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
50.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
40.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
OSE Immunotherapeutics SA's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, OSE Immunotherapeutics SA has total debt of 24.6m EUR. This includes both short-term (0 EUR) and long-term (24.6m EUR) debt.
You can find a full breakdown on its Balance Sheet.